滿地科技股份(01400.HK):因應公共衞生考慮 清盤呈請聆訊延期
格隆匯2月3日丨滿地科技股份(01400.HK)公佈,有關清盤呈請,司法機構已宣佈,因應公共衞生考慮,原訂由2020年2月3日至2020年2月9日於法院/審裁處進行的所有聆訊,包括原訂於2020年2月5日的呈請聆訊,將延期至另行通知的日期。
此外,於2020年1月24日,香港高等法院下達了一項命令,除了其他事項,確認對共同臨時清盤人之任命,並且只要公司仍在百慕達進行臨時清盤,除非獲得香港高等法院許可,並以香港法院可能施加之條款為準,不得針對公司,及其於香港法院管轄範圍內之資產或事務,或其財產進行及展開法律行動及訴訟程序。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.